Otsuka (OTCMKTS:OTSKY) Announces Quarterly Earnings Results, Beats Estimates By $0.05 EPS

Otsuka (OTCMKTS:OTSKY) released its earnings results on Friday. The company reported $0.64 EPS for the quarter, topping analysts’ consensus estimates of $0.59 by $0.05, Zacks reports. Otsuka had a net margin of 15.50% and a return on equity of 12.86%. The company had revenue of $4.51 billion for the quarter, compared to analysts’ expectations of $4.42 billion.

Otsuka Stock Down 2.4%

OTCMKTS OTSKY opened at $37.93 on Friday. The stock has a market cap of $40.74 billion, a PE ratio of 16.28, a PEG ratio of 2.72 and a beta of 0.09. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.65 and a current ratio of 2.21. Otsuka has a twelve month low of $26.11 and a twelve month high of $40.92. The firm has a 50-day simple moving average of $37.35 and a 200 day simple moving average of $34.83.

Analyst Ratings Changes

Separately, Zacks Research upgraded Otsuka from a “hold” rating to a “strong-buy” rating in a report on Friday, October 9th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy”.

Otsuka Company Profile

Otsuka Holdings Co, Ltd. is a Japan-based healthcare company that manages a group of businesses focused primarily on pharmaceuticals, nutraceuticals, and consumer health products. Through its subsidiaries, the company researches, develops, manufactures, and markets prescription medicines, over-the-counter products, functional foods, and beverages.

Its pharmaceutical operations address areas including psychiatry, oncology, cardiovascular and renal diseases, and several other specialty conditions.